These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19761396)
21. [Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up]. Gao LR; Wang ZG; Tian HT; Zhu ZM; Fei YX; Xu HT; Chen Y; Zhu JR; He S; Zhang NK; Ding QA; Yang Y Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):685-9. PubMed ID: 17553306 [TBL] [Abstract][Full Text] [Related]
22. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ; Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649 [TBL] [Abstract][Full Text] [Related]
23. [Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: a contrast-enhanced cardiac magnetic resonance study]. Villa A; Tejedor-Viñuela P; Sánchez PL; Tapia C; Arnold R; Gómez-Salvador I; García-Frade LJ; Sánchez A; Fernández-Avilés F; San Román JA Rev Esp Cardiol; 2008 Jun; 61(6):602-10. PubMed ID: 18570781 [TBL] [Abstract][Full Text] [Related]
24. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Schächinger V; Assmus B; Britten MB; Honold J; Lehmann R; Teupe C; Abolmaali ND; Vogl TJ; Hofmann WK; Martin H; Dimmeler S; Zeiher AM J Am Coll Cardiol; 2004 Oct; 44(8):1690-9. PubMed ID: 15489105 [TBL] [Abstract][Full Text] [Related]
25. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413 [TBL] [Abstract][Full Text] [Related]
26. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006 [TBL] [Abstract][Full Text] [Related]
27. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial. Drexler H; Meyer GP; Wollert KC Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634 [TBL] [Abstract][Full Text] [Related]
28. Clinical trials using autologous bone marrow and peripheral blood-derived progenitor cells in patients with acute myocardial infarction. Tendera M; Wojakowski W Folia Histochem Cytobiol; 2005; 43(4):233-5. PubMed ID: 16382891 [TBL] [Abstract][Full Text] [Related]
29. [Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up]. Tayyareci Y; Umman B; Sezer M; Beşişik S; Sanli Y; Mudun A; Gürses N; Nişanci Y Turk Kardiyol Dern Ars; 2008 Dec; 36(8):519-29. PubMed ID: 19223717 [TBL] [Abstract][Full Text] [Related]
30. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Li ZQ; Zhang M; Jing YZ; Zhang WW; Liu Y; Cui LJ; Yuan L; Liu XZ; Yu X; Hu TS Int J Cardiol; 2007 Jan; 115(1):52-6. PubMed ID: 16822566 [TBL] [Abstract][Full Text] [Related]
31. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function. Houtgraaf JH; de Jong R; Kazemi K; de Groot D; van der Spoel TI; Arslan F; Hoefer I; Pasterkamp G; Itescu S; Zijlstra F; Geleijnse ML; Serruys PW; Duckers HJ Circ Res; 2013 Jul; 113(2):153-66. PubMed ID: 23658436 [TBL] [Abstract][Full Text] [Related]
32. Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: a meta-analysis. Ye Z; Zhang BL; Zhao XX; Qin YW; Wu H; Cao J; Zhang JL; Hu JQ; Zheng X; Xu RL Heart Lung Circ; 2012 Nov; 21(11):725-33. PubMed ID: 22898593 [TBL] [Abstract][Full Text] [Related]
34. [Effects of intracoronary transplantation of autologous bone marrow mononuclear cells or endothelial progenitor cells in mini-swine model of myocardial ischemia-reperfusion]. Li CJ; Gao RL; Yang YJ; Hu FH; Yang WX; Song LF; Ruan YM; Qiao SB; Chen JL; Qin XW; Chen ZJ Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):936-9. PubMed ID: 18206044 [TBL] [Abstract][Full Text] [Related]
35. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials. Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043 [TBL] [Abstract][Full Text] [Related]
36. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Kang HJ; Kim HS; Koo BK; Kim YJ; Lee D; Sohn DW; Oh BH; Park YB Am Heart J; 2007 Feb; 153(2):237.e1-8. PubMed ID: 17239682 [TBL] [Abstract][Full Text] [Related]
37. Results of intracoronary stem cell therapy after acute myocardial infarction. Wöhrle J; Merkle N; Mailänder V; Nusser T; Schauwecker P; von Scheidt F; Schwarz K; Bommer M; Wiesneth M; Schrezenmeier H; Hombach V Am J Cardiol; 2010 Mar; 105(6):804-12. PubMed ID: 20211323 [TBL] [Abstract][Full Text] [Related]
38. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study. Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174 [TBL] [Abstract][Full Text] [Related]
39. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial. Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ; Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409 [TBL] [Abstract][Full Text] [Related]